The Middle East & Africa fill finish manufacturing market was valued at US$ 522.33 million in 2022 and is expected to reach US$ 953.58 million by 2030; it is estimated to record a CAGR of 7.8% from 2022 to 2030.
Bulk biotech operations have successfully deployed single-use systems for buffer and media preparations. They are currently implementing new single-use technologies such as fermentation and chromatography systems. Recent advancements in technology are making SUDS increasingly attractive for aseptic operations. For instance, a single-use line is a perfect fit for parenteral solution products with relatively low batch sizes (50-500L) that a peristaltic pump can transfer. Thus, rise in use of single use system for aseptic fill finish manufacturing will provide future trends in near future.
The government of South Africa is promoting and offering several incentives for domestic manufacturing of drugs, which, in turn, can fuel the overall market growth in this country in the coming years. Also, the country's healthcare system is developing at a rapid pace, as an increasing number of sponsors are developing medical and research teams in the country. A sharp increase in the state health budget is also expected to increase the demand for fill-finish manufacturing in the country.
Single-Use Systems for Aseptic Fill Finish Bolster Middle East & Africa Fill Finish Manufacturing Market
Single-use disposable systems (SUDS) and single-use systems (SUS) for aseptic fill finish save time for pharmaceutical manufacturers, thereby allowing them to streamline their operations and shorten project schedules. Incorporating SUDS also helps them ensure regulatory compliance as well as confer environmental, health, and safety (EHS) benefits and facility design advantages. Furthermore, SUS accelerates the change over fill finish operations by simplifying end-of-batch breakdown and decontamination operations; the simplification of decontamination operations involves the elimination of time-consuming cleaning and preparation steps. The SUS is now being used in fill-finish operations.Bulk biotech operations have successfully deployed single-use systems for buffer and media preparations. They are currently implementing new single-use technologies such as fermentation and chromatography systems. Recent advancements in technology are making SUDS increasingly attractive for aseptic operations. For instance, a single-use line is a perfect fit for parenteral solution products with relatively low batch sizes (50-500L) that a peristaltic pump can transfer. Thus, rise in use of single use system for aseptic fill finish manufacturing will provide future trends in near future.
Middle East & Africa Fill Finish Manufacturing Market Overview
South Africa is one of the fastest-growing countries in the Middle East & Africa, and the market growth is driven by a rise in research & development activities, including pharmaceutical and biotechnology-related activities, and growing number of healthcare facilities. The rise in awareness of health issues and increasing consumption of medication are other factors driving the market.The government of South Africa is promoting and offering several incentives for domestic manufacturing of drugs, which, in turn, can fuel the overall market growth in this country in the coming years. Also, the country's healthcare system is developing at a rapid pace, as an increasing number of sponsors are developing medical and research teams in the country. A sharp increase in the state health budget is also expected to increase the demand for fill-finish manufacturing in the country.
Middle East & Africa Fill Finish Manufacturing Market Segmentation
The Middle East & Africa fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Middle East & Africa fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.- In terms of modality, the Middle East & Africa fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.
- By end user, the Middle East & Africa fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.
- Based on country, the Middle East & Africa fill finish manufacturing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa fill finish manufacturing market share in 2022.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Middle East & Africa Fill Finish Manufacturing Market Landscape
5. Middle East & Africa Fill Finish Manufacturing Market - Key Industry Dynamics
7. Middle East & Africa Fill Finish Manufacturing Market Analysis - Product
8. Middle East & Africa Fill Finish Manufacturing Market Analysis - Modality
9. Middle East & Africa Fill Finish Manufacturing Market Analysis - End User
10. Middle East & Africa Fill Finish Manufacturing Market - Country Analysis
11. Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned
- Becton Dickinson and Co
- IMA Industria Macchine Automatiche SpA
- Maquinaria Industrial Dara SL
- Nipro Medical Europe NV
- Schott AG
- SGD SA
- Syntegon Technology GmbH
- West Pharmaceutical Services Inc
